Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. (NKF), headquartered in Nanjing, China, is a leading global biopharmaceutical enterprise dedicated to building an integrated platform for internationalization of its high-end injectables and to serve domestic pharmaceutical manufacturers in expanding their business around the globe. With over a dozen of ANDAs approved in US each year, NKF has grown into one of the biggest suppliers of high-end injectables in the US. NKF is also one of the biggest suppliers of Heparin APIs and finished dosage forms, and is actively working with partners from over 60 countries for over 65 USFDA approved products.